Healthcare -
Biotechnology - NASDAQ - US
$ 0.6581
-0.903 %
$ 83 M
Market Cap
-0.63
P/E
KPTI - OTHER CURRENT LIABILITIES
Other Current Liabilities KPTI - Karyopharm Therapeutics Inc.
63 M
LAST VALUE
-3.34%
2 YEAR CAGR
13.68%
5 YEAR CAGR
45.60%
10 YEAR CAGR